Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1161600 | 0.83 | CYP4F2 (0.52) | CYP4F2CYP4A11KDM4ELMNAHSD17B10 | |
| Hydrochloric Acid SCHEMBL6264005 | 0.81 | CYP4F2 (0.50) | CYP4F2CYP4A11KDM4ELMNAHSD17B10 | |
| SCHEMBL22926632 | 0.79 | CYP4F2 (0.40) | CYP4F2CYP4A11KDM4E | |
| SCHEMBL22926635 | 0.79 | KDM4E (0.40) | CYP4F2CYP4A11KDM4ECYP2D6 | |
| SCHEMBL24692370 | 0.79 | KDM4E (0.40) | CYP4F2CYP4A11KDM4ECYP2D6LMNA | |
| SCHEMBL41882 | 0.79 | — | — | |
| SCHEMBL22922997 | 0.78 | CYP4F2 (0.35) | CYP4F2CYP4A11KDM4ELMNAHSD17B10 | |
| SCHEMBL10407133 | 0.77 | — | — | |
| SCHEMBL291019 | 0.77 | — | — | |
| SCHEMBL22356273 | 0.76 | TET2 (0.36) | CYP4F2CYP4A11KDM4ELMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230266666-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230266666-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | H1-0, H1-4, CHRM1 | CYP4F2 1631/4885CYP4A11 591/4885KDM4E 2730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.